Tipirneni Praveen P. — SEC Form 4 filings
SEC reporting owner CIK 1779978. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-17 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 35,505 shares, $1,586,828 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 21,582 shares @ $55.79 ($1,204,075) in Morphic Holding, Inc., filed 2024-07-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Morphic Holding, Inc. (MORF) | President and CEO, Director | 3 | — | 2 legs · 35,505 sh · $1,586,828 | 19 |
| Tectonic Therapeutic, Inc. (TECX) | Director | 3 | — | — | 5 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | Director | 2 | — | — | 2 |
Form 4 filings — Tipirneni Praveen P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 31,675 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2025-08-28 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 52,269 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 10,200 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | Morphic Holding, Inc. (MORF) | Code (U): 42,460 · Code (U): 614,474 · Disposition to issuer (D): 339,561 (derivative) · Disposition to issuer (D): 273,350 (derivative) · Disposition to issuer (D): 205,000 (derivative) · Disposition to issuer (D): 224,016 (derivative) · +5 more | EDGAR |
| 2024-07-10 | 4 | Morphic Holding, Inc. (MORF) | Option exercise (M): 21,582 @ $4.32 · Sale (S): 21,582 @ $55.79 · Option exercise (M): 21,582 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 3,037 · Grant/award (A): 12,166 (derivative) · Grant/award (A): 11,760 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | Morphic Holding, Inc. (MORF) | Option exercise (M): 29,500 @ $0 · Option exercise (M): 12,500 @ $0 · Sale (S): 13,923 @ $27.49 · Grant/award (A): 206,400 (derivative) @ $0 · Grant/award (A): 136,800 (derivative) @ $0 · Option exercise (M): 29,500 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779978 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →